Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Spark New Zealand Limited | NZTA | Nov 15, 2024 | 8.45 | -0.59 |
Sparta AG | SPT6 | Nov 15, 2024 | 32.40 | 0.00 |
SPARTAN DELTA CORP. NEW | 4YJ0 | Nov 15, 2024 | 2.12 | +0.95 |
SPARTAN RESOURCES LTD. | 6G40 | Nov 15, 2024 | 0.65 | -3.70 |
SpartanNash Company | SRJ | Nov 15, 2024 | 16.90 | -1.17 |
Spartoo | 7ZP | Nov 15, 2024 | 0.41 | -0.49 |
SPEAR Investments I B.V | 7IO | Nov 15, 2024 | 4.76 | 0.00 |
Spearmint Resources Inc. Ordinary Shares (Canada) | SQH | Nov 15, 2024 | 0.01 | -1.72 |
Spectra7 Microsystems Inc | 7M0A | Nov 15, 2024 | 0.07 | -0.76 |
SpectraCure AB | 2OK | Nov 15, 2024 | 0.12 | +22.95 |
Spectral Medical Inc | SD4 | Nov 15, 2024 | 0.39 | +8.99 |
Spectris PLC | FA9 | Nov 15, 2024 | 30.40 | +2.01 |
Spectrum Brands Holdings, Inc. | H221 | Nov 15, 2024 | 83.50 | -5.65 |
SpectrumOne | 9TE | Nov 15, 2024 | 0.02 | +2.13 |
Speedy Hire Plc | 5HN | Nov 15, 2024 | 0.35 | -1.70 |
Speqta | 23WA | Nov 15, 2024 | 0.21 | -11.06 |
SPERMOSENS AB | 9R5 | Nov 15, 2024 | 0.00 | 0.00 |
Spero Therapeutics, Inc. | 2HA | Nov 15, 2024 | 1.16 | -2.68 |
Spey Resources | 2JS0 | Nov 15, 2024 | 0.06 | -45.00 |
SPH REIT Units | 50E | Nov 15, 2024 | 0.58 | +0.40 |
Sphere 3D | 8S3 | Nov 15, 2024 | 1.37 | -3.52 |
Sphere Entertainment | MQ2 | Nov 15, 2024 | 36.98 | -4.02 |
SPI Energy Co., Ltd. - Ordinary Shares | 7XSP | Nov 15, 2024 | 0.28 | +5.30 |
SPIE SA | 4SP | Nov 15, 2024 | 31.48 | +0.13 |
Spielvgg Unterhaching KGAA | S6P | Nov 15, 2024 | 3.10 | +16.54 |
Spiffbet | 2AK | Nov 15, 2024 | 0.00 | 0.00 |
Spin Master Corp | SP9 | Nov 15, 2024 | 20.60 | -1.90 |
Spineguard | 6W5 | Nov 15, 2024 | 0.18 | -0.32 |
Spinnova Oyj | 9HP | Nov 15, 2024 | 1.17 | -1.85 |
SPIR.COMMUN.ADR/ LS-,0333 | BW80 | Nov 15, 2024 | 8.00 | +1.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.